Fructose

aldo-keto reductase family 1 member B ; Homo sapiens







28 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35454074 In Search of Differential Inhibitors of Aldose Reductase. 2022 Mar 22 1
2 34120350 The role of thrifty genes in the origin of alcoholism: A narrative review and hypothesis. 2021 Aug 1
3 31589122 Natural Aldose Reductase Inhibitor: A Potential Therapeutic Agent for Non-alcoholic Fatty Liver Disease. 2020 1
4 32086945 Elevated Fructose and Uric Acid Through Aldose Reductase Contribute to Experimental and Human Alcoholic Liver Disease. 2020 Nov 5
5 30551808 Benzoxazinone-thiosemicarbazones as antidiabetic leads via aldose reductase inhibition: Synthesis, biological screening and molecular docking study. 2019 Jun 1
6 30023751 New Insights into the Catalytic Mechanism of Aldose Reductase: A QM/MM Study. 2017 Sep 30 1
7 23850972 Association study of sorbitol dehydrogenase -888G>C polymorphism with type 2 diabetic retinopathy in Caucasian-Brazilians. 2013 Oct 1
8 22911800 Aldolase B knockdown prevents high glucose-induced methylglyoxal overproduction and cellular dysfunction in endothelial cells. 2012 2
9 20466987 Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model. 2010 May 14 1
10 20520742 Elevated Serum Sorbitol and not Fructose in Type 2 Diabetic Patients. 2010 May 4 1
11 19224447 Localization of the polyol pathway in the human kidney. 2009 Apr 2
12 16278369 Polyol pathway in human epididymis and semen. 2006 Mar-Apr 1
13 16026266 Aldose reductase in diabetic microvascular complications. 2005 Jun 1
14 12615520 Polymorphisms of sorbitol dehydrogenase (SDH) gene and susceptibility to diabetic retinopathy. 2003 Apr 2
15 12792982 Effects of eparlestat on plasma levels of advanced glycation end products in patients with type 2 diabetes. 2003 Mar-Apr 1
16 12962626 X-ray crystallographic and kinetic studies of human sorbitol dehydrogenase. 2003 Sep 1
17 10923253 [Diabetic somatic polyneuropathy. Pathogenesis, clinical manifestations and therapeutic concepts]. 2000 Jun 1
18 9614624 Influence of interindividual variability of aldose reductase protein content on polyol-pathway metabolites and redox state in erythrocytes in diabetic patients. 1998 Jun 1
19 9183016 Identification and characterisation of a sequence related to human sorbitol dehydrogenase. 1997 May 1 1
20 8792096 Release of fructose and hexose phosphates from perivascular cells induced by low density lipoprotein and acceleration of protein glycation in vitro. 1996 Mar 1
21 8535074 Molecular genetic analysis of the human sorbitol dehydrogenase gene. 1995 Sep 1
22 7940997 Aldose reductase inhibitors and their potential for the treatment of diabetic complications. 1994 Aug 1
23 8330752 Peripheral nerve protein glycation and muscle fructolysis: evidence of abnormal carbohydrate metabolism in ALS. 1993 Jan-Feb 1
24 2118946 Effect of fructose supplementation on sorbitol accumulation and myo-inositol metabolism in cultured neuroblastoma cells exposed to increased glucose concentrations. 1990 Oct 2
25 3136330 Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy. 1988 Sep 1 1
26 3142503 Antioxidant status in an in vitro model for hyperglycemic lens cataract formation: effect of aldose reductase inhibitor statil. 1988 Oct 1
27 6425821 [Sorbitol pathway of glucose metabolism in streptozotocin diabetes of varying duration and severity]. 1984 Mar-Apr 1
28 6782033 The sorbitol pathway in the human lens: aldose reductase and polyol dehydrogenase. 1981 Mar 1